1. Home
  2. RCKT vs RBCAA Comparison

RCKT vs RBCAA Comparison

Compare RCKT & RBCAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • RBCAA
  • Stock Information
  • Founded
  • RCKT 1999
  • RBCAA 1974
  • Country
  • RCKT United States
  • RBCAA United States
  • Employees
  • RCKT N/A
  • RBCAA N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • RBCAA Major Banks
  • Sector
  • RCKT Health Care
  • RBCAA Finance
  • Exchange
  • RCKT Nasdaq
  • RBCAA Nasdaq
  • Market Cap
  • RCKT 1.1B
  • RBCAA 1.3B
  • IPO Year
  • RCKT N/A
  • RBCAA 1998
  • Fundamental
  • Price
  • RCKT $10.47
  • RBCAA $65.66
  • Analyst Decision
  • RCKT Strong Buy
  • RBCAA
  • Analyst Count
  • RCKT 10
  • RBCAA 0
  • Target Price
  • RCKT $48.80
  • RBCAA N/A
  • AVG Volume (30 Days)
  • RCKT 1.3M
  • RBCAA 22.7K
  • Earning Date
  • RCKT 03-04-2025
  • RBCAA 01-24-2025
  • Dividend Yield
  • RCKT N/A
  • RBCAA 2.75%
  • EPS Growth
  • RCKT N/A
  • RBCAA 12.83
  • EPS
  • RCKT N/A
  • RBCAA 5.14
  • Revenue
  • RCKT N/A
  • RBCAA $330,428,000.00
  • Revenue This Year
  • RCKT N/A
  • RBCAA N/A
  • Revenue Next Year
  • RCKT $225,168.40
  • RBCAA $3.87
  • P/E Ratio
  • RCKT N/A
  • RBCAA $12.78
  • Revenue Growth
  • RCKT N/A
  • RBCAA 6.29
  • 52 Week Low
  • RCKT $9.33
  • RBCAA $46.55
  • 52 Week High
  • RCKT $31.47
  • RBCAA $80.68
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 45.20
  • RBCAA 42.94
  • Support Level
  • RCKT $9.33
  • RBCAA $65.35
  • Resistance Level
  • RCKT $11.09
  • RBCAA $68.30
  • Average True Range (ATR)
  • RCKT 0.52
  • RBCAA 1.63
  • MACD
  • RCKT 0.11
  • RBCAA 0.14
  • Stochastic Oscillator
  • RCKT 53.77
  • RBCAA 44.65

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through six reportable segments. It has traditional banking which generates the majority of revenue, warehouse, mortgage banking, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

Share on Social Networks: